Related Experiment Video
Updated: Jul 3, 2026

08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
[Clinical-pathology relationship in bladder cancer].
P Navarro Medina1, A Blanco Diez, J L Artiles Hernández
1Servicio de Urología, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria. patricionm@terra.es
Actas Urologicas Espanolas
|July 9, 2008
Summary
Computerized Axial Tomography (TAC) has a limited role in staging muscle-invasive bladder cancer before radical cystectomy. Its accuracy is low, especially for advanced disease, suggesting restricted use could reduce costs without compromising surgical decisions.
Area of Science:
- Urology
- Oncology
- Radiology
Background:
- Muscle-invasive bladder cancer requires accurate staging for treatment planning.
- Radical cystectomy is a primary treatment option for this condition.
- Pre-operative imaging plays a crucial role in determining the extent of disease.
Purpose of the Study:
- To evaluate the effectiveness of Computerized Axial Tomography (TAC) in the pre-operative staging of muscle-invasive bladder cancer.
- To assess the accuracy of TAC in determining bladder (pT) and lymph node (pN) involvement.
- To analyze the impact of TAC findings on surgical management decisions.
Main Methods:
- Retrospective cohort study of 63 patients undergoing radical cystectomy for bladder cancer.
- Comparison of TAC staging with pathological anatomy results (TNM classification).
- Evaluation of TAC's impact on surgical approach.
Main Results:
- TAC correctly staged the bladder in only 28.6% of cases, with understaging in 50.8% and overstaging in 20.6%.
- TAC sensitivity for bladder cancer decreased with more advanced stages, while specificity increased (44% for pT2 to 94% for pT4).
- Lymph node staging by TAC was accurate in 73.5% of cases, primarily in node-negative patients, with low sensitivity (28%) and specificity (55%).
Conclusions:
- Computerized Axial Tomography (TAC) has a limited impact on the clinical staging of muscle-invasive bladder cancer.
- The primary benefit of TAC is in patients with suspected advanced disease.
- Restricting TAC use to these cases could significantly reduce costs with minimal risk of inappropriate surgical management.

